Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/1995
03/22/1995EP0527803B1 Composition for macrophage activation
03/22/1995CN1100413A Urethanes and ureas that induce cytokine production
03/22/1995CA2132479A1 Pharmaceutical composition for treating or preventing allergic rhinitis
03/21/1995US5399714 One-pot reduction; acylation
03/21/1995US5399703 Tetrazole derivatives and drugs
03/21/1995US5399698 Quinolin-2-yl-methoxybenzylhydroxyureas
03/21/1995US5399672 Coupling hapten to protein or polypeptide in solvent
03/21/1995US5399590 Treatment of skin tumors, rheumatic diseases
03/21/1995US5399575 Pyridine compounds which have useful pharmaceutical activity
03/21/1995US5399563 Benzylidenequinuclidinones
03/21/1995US5399341 Use of cytokin-containing aerosols and the cytokin-containing aerosols
03/16/1995WO1995007301A1 Recombinant il4 antibodies useful in treatment of il4 mediated disorders
03/16/1995WO1995007291A1 Kininogen inhibitors
03/16/1995WO1995007257A1 Difluoro statone antiviral analogs
03/16/1995WO1995007105A1 Haplotype-matched cytokine-secreting cells and methods of using to stimulate an immune response
03/16/1995WO1995007091A1 Uses of vegetable oils
03/16/1995WO1995007089A1 Immunomodulating compositions from bile
03/16/1995WO1995007073A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
03/16/1995WO1995003084A3 Extracorporeal affinity adsorption devices
03/16/1995WO1995000643A3 Human cell adhesion protein aamp-1 and uses thereof
03/16/1995CA2171211A1 Haplotype-matched cytokine-secreting cells and methods of using to stimulate an immune response
03/16/1995CA2170896A1 Kininogen inhibitors
03/15/1995EP0643077A1 Monoclonal antibody against B70 molecule
03/15/1995EP0642577A1 Antibodies with specificity for multiple adhesion molecules
03/15/1995EP0642516A1 Macrocyclic immunomodulators
03/15/1995EP0642513A1 Indolocarbazole imides and their use
03/15/1995EP0642489A1 Cyclopentane and cyclopentene derivatives with antiallergic antiinflammatory and tumor necrosis factor inhibiting activity
03/15/1995EP0642351A1 New pharmaceutical uses of krill enzymes
03/15/1995EP0642342A1 Selective cell inactivation in blood
03/15/1995EP0642333A1 Method and composition for the treatment of disorders involving immunological dysfunction
03/15/1995EP0642332A1 Ophthalmic compositions containing a cyclosporin.
03/15/1995EP0394333B1 Uses of sulphated sugars
03/15/1995CN1100090A Amine derivatives of oxo- and hydroxy-substituted hydrocarbons
03/14/1995US5397703 Method for generation of antibodies to cell surface molecules
03/14/1995US5397569 Method of treating Infectious Bursal Disease Virus infections
03/14/1995CA1334753C Glycerin derivative and its pharmacological use
03/09/1995WO1995006728A2 T cell epitopes of ryegrass pollen allergen
03/09/1995WO1995006727A2 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease
03/09/1995WO1995006725A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen
03/09/1995WO1995006718A2 Methods of suppressing autoimmune response
03/09/1995WO1995006717A2 Methods of suppressing graft rejection
03/09/1995WO1995006666A1 Anti-gp39 antibodies and uses therefor
03/09/1995WO1995006654A1 Glycosyl amides of 2-aminoacylamino-2-deoxy sugars
03/09/1995WO1995006645A1 Benzofuran derivatives as tachykinin antagonists
03/09/1995WO1995006640A1 Carbocyclic and heterocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
03/09/1995WO1995006481A1 Methods for inducing antigen-specific t cell tolerance
03/09/1995WO1995006480A1 Methods of prolonged suppression of humoral immunity
03/09/1995WO1995006465A1 Thiol compounds for strengthening the immune system and immune reactions
03/09/1995WO1995006464A1 Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa
03/09/1995WO1995006410A1 Treatment of chronic inflammatory diseases by angiotension ii receptor antagonists
03/09/1995WO1995001348A3 Imides as inhibitors of tnp alpha
03/09/1995CA2170901A1 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease
03/09/1995CA2170395A1 Glycosyl amides of 2-aminoacylamino-2-deoxy sugars
03/09/1995CA2170390A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen
03/09/1995CA2170349A1 Carbocyclic and heterocyclic fused-ring quinolinecarboxylic acids useful as immunosuppresive agents
03/09/1995CA2168565A1 T cell epitopes of ryegrass pollen allergen
03/09/1995CA2158933A1 Methods of suppressing graft rejection
03/09/1995CA2158932A1 Methods of suppressing autoimmune response
03/09/1995CA2131512A1 Nutritional supplement
03/08/1995EP0641562A1 Nutritional supplement
03/08/1995EP0641344A1 8-substituted anthines as phosphodiesterase inhibitors
03/08/1995EP0641327A1 Novel alpha-mannosidase inhibitors
03/08/1995EP0641319A1 N- N'-(5-AMINO-4-HYDROXY-ACYLOYL)-$g(a)-AMINOACYLOYL] SUBSTITUTED HETEROCYCLES AND THEIR USE AS ANTIVIRAL AGENTS
03/08/1995EP0559743B1 Novel hydroxamic acid and n-hydroxyurea derivatives and their use
03/08/1995CN1099756A Tetrahydropyran derivatives
03/07/1995US5395957 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds
03/07/1995US5395834 New benzopyran compounds
03/02/1995WO1995006122A2 Recombinant alternaria alternata allergenes
03/02/1995WO1995006121A2 Recombinant cladosporium herbarum allergens
03/02/1995WO1995006118A1 Expression control sequences of the p-selectin gene
03/02/1995WO1995006077A2 Polymeric matrices and their uses in pharmaceutical compositions
03/02/1995WO1995006034A1 Compounds and methods for inhibition of hiv and related viruses
03/02/1995WO1995005853A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
03/02/1995WO1995005852A1 Agent against sensitive, hyperreactive and hypoactive states of the skin, forms of acne, atopic dermatitides, psoriasis, prurigo, photodermatoses, ichthyosis and viral infections
03/02/1995WO1995005849A1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes
03/02/1995WO1995005841A1 Novel tripeptides useful in immune and cns therapy
03/02/1995WO1995005833A1 Pharmaceutical composition for immunoenhancement therapy
03/02/1995WO1995005814A1 Pharmaceutical compositions comprising metal complexes
03/02/1995CA2623540A1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies
03/02/1995CA2170356A1 Recombinant cladosporium herbarum allergens
03/02/1995CA2170355A1 Recombinant alternaria alternata allergenes
03/02/1995CA2170253A1 Pharmaceutical compositions comprising metal complexes
03/02/1995CA2169941A1 Expression control sequences of the p-selectin gene
03/02/1995CA2169072A1 Novel tripeptides useful in immune and cns therapy
03/01/1995EP0640689A2 p40 Homodimer of interleukin-12
03/01/1995EP0640613A1 OLIGOSIALYL-1,2-DIALKYL-Sn-GLYCEROL AND INTERMEDIATE FOR ITS SYNTHESIS
03/01/1995EP0640346A1 Uses of sulphated sugars against inflammation
03/01/1995EP0640345A2 Composition for inhibiting transmission of AIDS, containing silver salts with a detergent
03/01/1995EP0640101A1 Methods and reagents for diagnosis of autoantibodies
03/01/1995EP0640087A1 Use of tricyclic pyrimidine derivatives as anti-viral medicaments
03/01/1995EP0639979A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
03/01/1995EP0639975A1 Heterocyclic-substituted pyridine compounds and uses
03/01/1995EP0547090B1 Phenolic thioetheramides as 5-lipoxygenase inhibitors
03/01/1995EP0462264B1 Heterocyclic derivatives, method for preparing same, and their therapeutic applications as paf-antagonists
03/01/1995EP0456833B1 Immunosuppressant and process for preparing the same
02/1995
02/28/1995US5393788 Administering in the treatment of asthma or an allergic or inflammatory disease
02/28/1995US5393775 Benzopyran compounds
02/28/1995US5393768 Treating hypersensitivity reactions such as asthma
02/28/1995US5393753 Substituted imidazobenzazepines
02/28/1995US5393740 Neurotensin Hexapeptides